| |
| |
|
| Insider
Information: |
Gonella Jacques |
| Relationship: |
Director |
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
9,385,848 |
|
|
Indirect Shares
|
2,900,000 |
|
|
| Direct
Value |
$52,466,890 |
|
|
|
Indirect Value
|
$16,211,000 |
|
|
| Total
Shares |
12,285,848 |
|
|
| Total
Value |
$68,677,890 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Antares Pharma Inc |
ATRS |
Director |
2019-02-26 |
9,385,848 |
2008-06-04 |
2,900,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2019-02-26 |
4 |
AS |
$3.65 |
$730,000 |
D/D |
(200,000) |
9,385,848 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-10-02 |
4 |
AS |
$3.79 |
$1,516,000 |
D/D |
(400,000) |
9,585,848 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-08-13 |
4 |
AS |
$3.09 |
$152,977 |
D/D |
(49,507) |
9,985,848 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-08-08 |
4 |
AS |
$3.09 |
$774,023 |
D/D |
(250,493) |
10,035,355 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-06-15 |
4 |
S |
$2.95 |
$1,667 |
D/D |
(565) |
10,285,848 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-06-12 |
4 |
S |
$2.77 |
$277,000 |
D/D |
(100,000) |
10,286,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-06-11 |
4 |
S |
$2.69 |
$269,000 |
D/D |
(100,000) |
10,386,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-06-06 |
4 |
S |
$2.70 |
$54,699 |
D/D |
(20,259) |
10,486,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-06-05 |
4 |
S |
$2.70 |
$62,448 |
D/D |
(23,129) |
10,506,672 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-06-05 |
4 |
S |
$2.55 |
$255,000 |
D/D |
(100,000) |
10,529,801 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-06-04 |
4 |
S |
$2.65 |
$265,000 |
D/D |
(100,000) |
10,629,801 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-06-01 |
4 |
S |
$2.60 |
$205,239 |
D/D |
(78,938) |
10,786,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-06-01 |
4 |
S |
$2.70 |
$152,852 |
D/D |
(56,612) |
10,729,801 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-30 |
4 |
S |
$2.55 |
$255,000 |
D/D |
(100,000) |
10,865,351 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-23 |
4 |
S |
$2.50 |
$489,545 |
D/D |
(194,682) |
10,965,351 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-22 |
4 |
S |
$2.53 |
$13,455 |
D/D |
(5,318) |
11,160,033 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-18 |
4 |
S |
$2.60 |
$54,761 |
D/D |
(21,062) |
11,165,351 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-17 |
4 |
S |
$2.55 |
$255,000 |
D/D |
(100,000) |
11,186,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-16 |
4 |
S |
$2.52 |
$252,000 |
D/D |
(100,000) |
11,286,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-15 |
4 |
S |
$2.50 |
$250,000 |
D/D |
(100,000) |
11,386,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-14 |
4 |
S |
$2.50 |
$250,000 |
D/D |
(100,000) |
11,486,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-11 |
4 |
S |
$2.47 |
$247,000 |
D/D |
(100,000) |
11,586,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-10 |
4 |
S |
$2.36 |
$236,000 |
D/D |
(100,000) |
11,686,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-09 |
4 |
AS |
$2.46 |
$740,400 |
D/D |
(300,000) |
11,786,413 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2018-05-03 |
4 |
OE |
$0.85 |
$25,500 |
D/D |
30,000 |
12,086,413 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
